Back to Search Start Over

High throughput generation of a resource of the human secretome in mammalian cells

Authors :
Tegel, Hanna
Dannemeyer, Melanie
Kanje, Sara
Sivertsson, Åsa
Berling, Anna
Svensson, Anne-Sophie
Hober, Andreas
Enstedt, Henric
Volk, Anna-Luisa
Lundqvist, Magnus
Moradi, Mona
Afshari, Delaram
Ekblad, Siri
Xu, LanLan
Vestin, Malin
Bidad, Faranak
Schiavone, Lovisa Holmberg
Davies, Rick
Mayr, Lorenz M.
Knight, Sinead
Gopel, Sven O.
Voldborg, Bjorn G.
Edfors, Fredrik
Forsström, Björn
von Feilitzen, Kalle
Zwahlen, Martin
Rockberg, Johan
Takanen, Jenny Ottosson
Uhlén, Mathias
Hober, Sophia
Tegel, Hanna
Dannemeyer, Melanie
Kanje, Sara
Sivertsson, Åsa
Berling, Anna
Svensson, Anne-Sophie
Hober, Andreas
Enstedt, Henric
Volk, Anna-Luisa
Lundqvist, Magnus
Moradi, Mona
Afshari, Delaram
Ekblad, Siri
Xu, LanLan
Vestin, Malin
Bidad, Faranak
Schiavone, Lovisa Holmberg
Davies, Rick
Mayr, Lorenz M.
Knight, Sinead
Gopel, Sven O.
Voldborg, Bjorn G.
Edfors, Fredrik
Forsström, Björn
von Feilitzen, Kalle
Zwahlen, Martin
Rockberg, Johan
Takanen, Jenny Ottosson
Uhlén, Mathias
Hober, Sophia
Publication Year :
2020

Abstract

The proteins secreted by human tissues and blood cells, the secretome, are important both for the basic understanding of human biology and for identification of potential targets for future diagnosis and therapy. Here, a high-throughput mammalian cell factory is presented that was established to create a resource of recombinant full-length proteins covering the majority of those annotated as 'secreted' in humans. The full-length DNA sequences of each of the predicted secreted proteins were generated by gene synthesis, the constructs were transfected into Chinese hamster ovary (CHO) cells and the recombinant proteins were produced, purified and analyzed. Almost 1,300 proteins were successfully generated and proteins predicted to be secreted into the blood were produced with a success rate of 65%, while the success rates for the other categories of secreted proteins were somewhat lower giving an overall one-pass success rate of ca. 58%. The proteins were used to generate targeted proteomics assays and several of the proteins were shown to be active in a phenotypic assay involving pancreatic beta-cell dedifferentiation. Many of the proteins that failed during production in CHO cells could be rescued in human embryonic kidney (HEK 293) cells suggesting that a cell factory of human origin can be an attractive alternative for production in mammalian cells. In conclusion, a high-throughput protein production and purification system has been successfully established to create a unique resource of the human secretome.<br />QC 20200729

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1235079298
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1016.j.nbt.2020.05.002